Korean Circulation Journal

  • 제43권11호
  • /
  • Pages.713-722
  • /
  • 2013
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Development of a Rabbit Model for a Preclinical Comparison of Coronary Stent Types In-Vivo

  • Lee, Joo Myung (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) ;
  • Lee, Jaewon (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) ;
  • Jeong, Heewon (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) ;
  • Choe, Won Seok (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) ;
  • Seo, Won-Woo (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) ;
  • Lim, Woo-Hyun (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) ;
  • Kim, Young-Chan (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) ;
  • Hur, Jin (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) ;
  • Lee, Sang Eun (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) ;
  • Yang, Han-Mo (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) ;
  • Cho, Hyun-Jai (Innovative Research Institute for Cell Therapy, Seoul National University Hospital) ;
  • Kim, Hyo-Soo (Innovative Research Institute for Cell Therapy, Seoul National University Hospital)
  • 투고 : 2013.06.28
  • 심사 : 2013.09.03
  • 발행 : 2013.11.30
⟨ 이전 논문 다음 논문 ⟩

초록

Along with the development of innovative stent designs, preclinical trials in animal models are essential. Many animal models have been used and appear to yield comparable results to clinical trials despite substantial criticisms about their validity. Among the animal models, porcine coronary artery models have been the standard models for the preclinical evaluation of endovascular devices. However, rapid growth rate, high body weight potential, and the propensity to develop granulomatous inflammatory reactions are major limitations of the porcine coronary artery model. Compared with porcine coronary artery models, the comparative rabbit iliac artery model has the advantages of being small and easy to handle and relatively inexpensive. Furthermore, the rabbit model has been known to reliably reflect human restenosis histopathologically and have major advantages such as pairwise comparison, which makes each animal serve as its own control subject, therefore, maximizing its statistical power for comparative testing. However, despite the widespread use of this model, a systematic description of the procedure and harvest protocols has never been published. This article describes the surgical procedure, stent implantation procedure, method for tissue harvesting, and how measurements are performed. Although the results of animal models may not perfectly extrapolate to humans, the comparative rabbit iliac artery model may be a useful tool for assessing and comparing the efficacy of new coronary stents with conventional stent systems. This thorough description of the techniques required for vascular access, stent implantation, tissue preparation, and measurement, should aid investigators wishing to begin using the comparative rabbit iliac artery model.

키워드

참고문헌

  1. Simsek C, Serruys PW. Developments in coronary artery stenting: primum non nocere. Panminerva Med 2011;53:19-30.
  2. Fischman DL, Leon MB, Baim DS, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N Engl J Med 1994;331:496-501. https://doi.org/10.1056/NEJM199408253310802
  3. Serruys PW, van Hout B, Bonnier H, et al. Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (benestent II). Lancet 1998; 352:673-81. https://doi.org/10.1016/S0140-6736(97)11128-X
  4. Cook S, Ladich E, Nakazawa G, et al. Correlation of intravascular ultrasound findings with histopathological analysis of thrombus aspirates in patients with very late drug-eluting stent thrombosis. Circulation 2009;120:391-9. https://doi.org/10.1161/CIRCULATIONAHA.109.854398
  5. Finn AV, Kolodgie FD, Harnek J, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimusor paclitaxel-eluting stents. Circulation 2005;112:270-8. https://doi.org/10.1161/CIRCULATIONAHA.104.508937
  6. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020-9. https://doi.org/10.1056/NEJMoa067731
  7. Rogers C, Edelman ER. Endovascular stent design dictates experimental restenosis and thrombosis. Circulation 1995;91:2995-3001. https://doi.org/10.1161/01.CIR.91.12.2995
  8. Carter AJ, Aggarwal M, Kopia GA, et al. Long-term effects of polymerbased, slow-release, sirolimus-eluting stents in a porcine coronary model. Cardiovasc Res 2004;63:617-24. https://doi.org/10.1016/j.cardiores.2004.04.029
  9. Serruys PW, Kutryk MJ, Ong AT. Coronary-artery stents. N Engl J Med 2006;354:483-95. https://doi.org/10.1056/NEJMra051091
  10. Akin I, Schneider H, Ince H, et al. Second- and third-generation drugeluting coronary stents: progress and safety. Herz 2011;36:190-6. https://doi.org/10.1007/s00059-011-3458-z
  11. Garg S, Serruys PW. Coronary stents: looking forward. J Am Coll Cardiol 2010;56(10 suppl):S43-78. https://doi.org/10.1016/j.jacc.2010.06.008
  12. Touchard AG, Schwartz RS. Preclinical restenosis models: challenges and successes. Toxicol Pathol 2006;34:11-8. https://doi.org/10.1080/01926230500499407
  13. Robert R, Rioufol G, Finet G, et al. Experimental assessment of new stent technologies: validation of a comparative paired rabbit iliac artery study model. J Biomed Mater Res B Appl Biomater 2004;70:303-10.
  14. Schwartz RS, Chronos NA, Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol 2004;44:1373-85.
  15. Nakamura T, Winsor-Hines D, Yin X, et al. Vasomotor function and reendothelialisation after implantation of biodegradable abluminal polymer coated paclitaxel-eluting stents in rabbit iliac arteries: a timecourse study. EuroIntervention 2012;8:493-500. https://doi.org/10.4244/EIJV8I4A77
  16. Nakazawa G, Nakano M, Otsuka F, et al. Evaluation of polymer-based comparator drug-eluting stents using a rabbit model of iliac artery atherosclerosis. Circ Cardiovasc Interv 2011;4:38-46. https://doi.org/10.1161/CIRCINTERVENTIONS.110.957654
  17. Doerning BJ, Brammer DW, Chrisp CE, Rush HG. Nephrotoxicity of tiletamine in New Zealand white rabbits. Lab Anim Sci 1992;42:267-9.
  18. Cho HJ, Kim HS, Lee MM, et al. Mobilized endothelial progenitor cells by granulocyte-macrophage colony-stimulating factor accelerate reendothelialization and reduce vascular inflammation after intravascular radiation. Circulation 2003;108:2918-25. https://doi.org/10.1161/01.CIR.0000097001.79750.78
  19. Van Dyck CJ, Hoymans VY, Bult H, et al. Resolute and Xience V polymerbased drug-eluting stents compared in an atherosclerotic rabbit double injury model. Catheter Cardiovasc Interv 2013;81:E259-68. https://doi.org/10.1002/ccd.24595
  20. Sommer CM, Grenacher L, Stampfl U, et al. Impact of stent design on in-stent stenosis in a rabbit iliac artery model. Cardiovasc Intervent Radiol 2010;33:565-75. https://doi.org/10.1007/s00270-009-9757-6
  21. Robertson SA, Eberhart S. Efficacy of the intranasal route for administration of anesthetic agents to adult rabbits. Lab Anim Sci 1994;44: 159-65.
  22. Che HL, Bae IH, Lim KS, et al. Suppression of post-angioplasty restenosis with an Akt1 siRNA-embedded coronary stent in a rabbit model. Biomaterials 2012;33:8548-56. https://doi.org/10.1016/j.biomaterials.2012.07.045
  23. Lim WH, Seo WW, Choe W, et al. Stent coated with antibody against vascular endothelial-cadherin captures endothelial progenitor cells, accelerates re-endothelialization, and reduces neointimal formation. Arterioscler Thromb Vasc Biol 2011;31:2798-805. https://doi.org/10.1161/ATVBAHA.111.226134
  24. Lee JM, Choe W, Kim BK, et al. Comparison of endothelialization and neointimal formation with stents coated with antibodies against CD34 and vascular endothelial-cadherin. Biomaterials 2012;33:8917-27. https://doi.org/10.1016/j.biomaterials.2012.08.066
  25. Van Belle E, Tio FO, Couffinhal T, Maillard L, Passeri J, Isner JM. Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. Circulation 1997;95:438-48. https://doi.org/10.1161/01.CIR.95.2.438
  26. Bayes-Genis A, Kantor B, Keelan PC, et al. Restenosis and hyperplasia: Animal Models. Curr Interv Cardiol Rep 2000;2:303-8.
  27. Perkins LE. Preclinical models of restenosis and their application in the evaluation of drug-eluting stent systems. Vet Pathol 2010;47:58-76. https://doi.org/10.1177/0300985809352978
  28. Asada Y, Kisanuki A, Tsuneyoshi A, Marutsuka K, Hatakeyama K, Sumiyoshi A. Effects of inflation pressure of balloon catheter on vascular injuries and subsequent development of intimal hyperplasia in rabbit aorta. Atherosclerosis 1996;121:45-53. https://doi.org/10.1016/0021-9150(95)05682-3
  29. Lowe HC, Schwartz RS, Mac Neill BD, et al. The porcine coronary model of in-stent restenosis: current status in the era of drug-eluting stents. Catheter Cardiovasc Interv 2003;60:515-23. https://doi.org/10.1002/ccd.10705

피인용 문헌

  1. Adenosine as a Marker and Mediator of Cardiovascular Homeostasis: A Translational Perspective vol.19, pp.2, 2019, https://doi.org/10.2174/1871529x18666181011103719